---
layout: single
title: "Curriculum Vitae"
permalink: /cv/
author_profile: true
---

# Meghna Verma, Ph.D.Â Â 
Associate Director, Systems Medicine | Clinical Pharmacology & Quantitative PharmacometricsÂ Â 
AstraZeneca, Gaithersburg, MD, USAÂ Â 

ðŸ“§ [meghnaverma.phd@gmail.com](mailto:meghnaverma.phd@gmail.com)Â Â 
ðŸ“± Â Â 
ðŸ”— [GitHub](https://github.com/meghna-verma) | [ORCID](https://orcid.org/0000-0002-7776-0433) | [LinkedIn](https://linkedin.com/in/YOUR-LINKEDIN)Â Â 

---

## ðŸ”¹ Summary
PhD with 5+ years of industry experience at AstraZeneca supporting **Model-Informed Drug Development (MIDD)**.Â Â 
Expertise in **QSP, PK/PD, viral dynamics, cytokine release, TCE models**, and regulatory submissions (EUA, IND).Â Â 

---

## ðŸ’¼ Professional Experience

### AstraZeneca â€” Associate Director, Systems MedicineÂ Â 
*Jan 2020 â€“ Present*Â Â 
- Developed **QSP trimer-based TCE models** for autoimmune diseases, supporting IND filing of *AZD0486*.Â Â 
- Built **cytokine release models** to assess safety and dosing strategies.Â Â 
- Led **viral dynamics modeling** of SARS-CoV-2, contributing to EUA approval of *EVUSHELD*.Â Â 
- Drafted ICH-compliant **modeling reports** and regulatory responses (FDA, EMA, HC, Swissmedic).Â Â 
- Championed **modeling templates** for reproducibility and regulatory consistency.Â Â 

---

### Virginia Tech â€” Graduate Research AssistantÂ Â 
*Aug 2015 â€“ Dec 2019*Â Â 
- Built **agent-based and ODE models** of immune responses (*C. difficile*, *H. pylori*).Â Â 
- Developed **HIV/HPV co-infection models** in MATLAB and COPASI.Â Â 
- Applied ML for **Crohnâ€™s disease in silico clinical trials**.Â Â 
- **Original website content (archived):**Â Â 
Â  > I developed a mechanistic ordinary differential-equation (ODE) simulation model of HIV/HPV coinfection and studied antiretroviral treatment effects in silico.Â Â 
Â  > Designed hybrid modeling frameworks integrating agent-based and differential equations for infectious disease simulations.Â Â 
Â  > Built surrogate AI-driven models to accelerate QSP virtual population generation.Â Â 

---

### University of Virginia â€” Graduate Research AssistantÂ Â 
*Feb 2015 â€“ Jun 2015*Â Â 
- Modeled influenza vaccination effectiveness in **urban vs rural US populations**.Â Â 

---

## ðŸŽ“ Education
- **Ph.D. Translational Biology, Medicine & Health (Computational Immunology)** â€” Virginia Tech, 2019Â Â 
- **M.S. Biomedical Engineering (Bioinformatics)** â€” Drexel University, 2014Â Â 
- **B.E. Biomedical Engineering** â€” Mumbai University, 2011Â Â 

---

## ðŸ›  Skills
- Modeling: QSP, PK/PD, viral dynamics, disease progressionÂ Â 
- Tools: MATLAB, R, Python, MONOLIX, GitÂ Â 
- AI/Automation: ChatGPT, Gemini, Claude, GitHub CopilotÂ Â 
- Regulatory Writing: IND, EUA, ICH M15Â Â 

---

## ðŸ† Awards & Recognition
- AZ CEO Award â€” COVID-19 modelingÂ Â 
- AZ Global Head AI Award â€” Cytokine release modelingÂ Â 
- EVUSHELD approval contributions â€” Biopharm R&D AwardÂ Â 
- Travel awards â€” ISCB, SBHD, SAMSI, VT GSAÂ Â 

---

## ðŸ“š Selected Publications
- Volkova S, **Verma M**, et al. (2025). *IFN-mediated inflammation in SLE*. **CPT:PSP**Â Â 
- Beattie KA, **Verma M**, et al. (2024). *Quantitative systems toxicology modeling*. **CPT:PSP**Â Â 
- Lai C, **Verma M**, et al. (2024). *T-cell engager modeling*. **Front Pharmacol**Â Â 
- **Verma M**, Gall L, et al. (2023). *Case studies in QSP for MIDD*. **Front Syst Biol**Â Â 
- Full list on [ORCID](https://orcid.org/0000-0002-7776-0433)Â Â 

---

## ðŸ“„ Download CV
For a PDF version: [Download here](/files/Verma_CV.pdf)
